Bioanalytical method for NAD<sup>+</sup> detection in blood plasma utilizing solution-phase Candida boidinii formate dehydrogenase and electrochemical detection
Issued Date
2025-01-01
Resource Type
ISSN
00032654
eISSN
13645528
Scopus ID
2-s2.0-85216970010
Journal Title
Analyst
Rights Holder(s)
SCOPUS
Bibliographic Citation
Analyst (2025)
Suggested Citation
Taron W., Kasemphong T., Sunon P., Kaewket K., Kamonsutthipaijit N., Ketudat-Cairns J.R., Bhakdisongkhram G., Tulalamba W., Sanguansuk S., Viprakasit V., Ngamchuea K. Bioanalytical method for NAD<sup>+</sup> detection in blood plasma utilizing solution-phase Candida boidinii formate dehydrogenase and electrochemical detection. Analyst (2025). doi:10.1039/d4an01560f Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/105281
Title
Bioanalytical method for NAD<sup>+</sup> detection in blood plasma utilizing solution-phase Candida boidinii formate dehydrogenase and electrochemical detection
Corresponding Author(s)
Other Contributor(s)
Abstract
Nicotinamide adenine dinucleotide is a crucial coenzyme in cellular metabolism and is implicated in various diseases. This work introduces an electrochemical bioanalytical method utilizing solution-phase Candida boidinii formate dehydrogenase (CbFDH) for detecting its oxidized form (NAD+) in human blood plasma samples. The detection mechanism involves the catalytic conversion of NAD+ to NADH, facilitated by CbFDH in the presence of formate. This NADH is then quantified by electrochemical measurements at disposable carbon screen-printed electrodes. The reaction is completed within one minute. The assay exhibits a linear response range from 3.74 μM to 2.00 mM, a sensitivity of 8.98 ± 0.18 μA mM−1, and a limit of detection (3sb/m) of 1.12 μM. It demonstrates selectivity against common interferences found in plasma samples, including glucose, urea, creatinine, guanosine 5′-monophosphate, cytidine 5′-monophosphate, flavin adenine dinucleotide, adenosine 5′-triphosphate, and lactate, with interference levels below 5% relative to the unperturbed NAD+ signal. Recovery studies showed 98.0-104.4% recoveries, with further validation against a colorimetric alcohol dehydrogenase assay confirming accuracy in plasma samples.
